AI News Sentiment & Analysis
Cogent Biosciences, Inc. (COGT) — AI News Sentiment & Analysis
4 recent AI analyses of Cogent Biosciences, Inc. (COGT) stock news and press releases, with sentiment and confidence scoring updated continuously.
Cogent Biosciences Submits New Drug Application for Bezuclastinib in Advanced Systemic Mastocytosis
BullishRegulatory DecisionSubmission of New Drug Application (NDA) for bezuclastinib in Advanced Systemic Mastocytosis (AdvSM) to the FDA. (Timing: FDA decision likely within 6-10 months post-submission.)Jun 30, 2026Cogent Biosciences Presents Strong Phase 3 Data for Bezuclastinib in GIST, De-risking Regulatory Pathway Ahead of FDA Decision
BullishClinical ResultsFDA approval of bezuclastinib combination for GIST patients following Priority Review acceptance. (Timing: November 30, 2026 (PDUFA date))May 30, 2026Cogent Biosciences' GIST Drug NDA Accepted by FDA with Priority Review
BullishRegulatory DecisionFDA acceptance of New Drug Application (NDA) for bezuclastinib in GIST with Priority Review, setting a PDUFA date, builds on strong Phase 3 results. (Timing: PDUFA date is November 30, 2026.)May 28, 2026Cogent Biosciences to Present Positive Phase 3 PEAK Trial Results for Bezuclastinib at ASCO, Catalyzing Potential Re-rating
BullishOral presentation of positive Phase 3 PEAK trial data for bezuclastinib in Gastrointestinal Stromal Tumors (GIST) at the ASCO Annual Meeting. (Timing: May 29 - June 2, 2026)Apr 21, 2026
Want the full picture?
These are AI analyses of recent press releases. Sign up to see full reasoning, confidence details, and get real-time alerts.
Sign Up for FreeFrequently Asked Questions
Is Cogent Biosciences, Inc. (COGT) bullish or bearish right now?
AI Sentiment on COGT: 4 Bullish.
What was the latest AI analysis for Cogent Biosciences, Inc. (COGT)?
The latest analysis was published on 6/30/2026 with the headline: "Cogent Biosciences Submits New Drug Application for Bezuclastinib in Advanced Systemic Mastocytosis".
How does Bekodia analyze Cogent Biosciences, Inc. (COGT) stock?
Bekodia uses advanced AI models to process Cogent Biosciences, Inc. (COGT) press releases and news in real-time, extracting sentiment, confidence scores, and key catalysts while filtering out market noise.